Personal genomics services: whose genomes?

New companies offering personal whole-genome information services over the internet are dynamic and highly visible players in the personal genomics field. For fees currently ranging from US$399 to US$2500 and a vial of saliva, individuals can now purchase online access to their individual genetic information regarding susceptibility to a range of chronic diseases and phenotypic traits based on a genome-wide SNP scan. Most of the companies offering such services are based in the United States, but their clients may come from nearly anywhere in the world. Although the scientific validity, clinical utility and potential future implications of such services are being hotly debated, several ethical and regulatory questions related to direct-to-consumer (DTC) marketing strategies of genetic tests have not yet received sufficient attention. For example, how can we minimize the risk of unauthorized third parties from submitting other people's DNA for testing? Another pressing question concerns the ownership of (genotypic and phenotypic) information, as well as the unclear legal status of customers regarding their own personal information. Current legislation in the US and Europe falls short of providing clear answers to these questions. Until the regulation of personal genomics services catches up with the technology, we call upon commercial providers to self-regulate and coordinate their activities to minimize potential risks to individual privacy. We also point out some specific steps, along the trustee model, that providers of DTC personal genomics services as well as regulators and policy makers could consider for addressing some of the concerns raised below.

[1]  Erratum: Looking forward, looking back , 2008, Nature Biotechnology.

[2]  J. Fox What price personal genome exploration? , 2008, Nature Biotechnology.

[3]  Yael Bregman-Eschet,et al.  Genetic Databases and Biobanks: Who Controls Our Genetic Privacy? , 2006 .

[4]  M. Wadman Gene-testing firms face legal battle , 2008, Nature.

[5]  Gail Javitt,et al.  The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. , 2008, Annual review of genomics and human genetics.

[6]  E. Kloza,et al.  Cystic Fibrosis Prenatal Screening in Genetic Counseling Practice: Recommendations of the National Society of Genetic Counselors , 2005, Journal of Genetic Counseling.

[7]  N. Blow Genomics: The personal side of genomics , 2007, Nature.

[8]  J. Berliner,et al.  Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic Counselors , 2007, Journal of Genetic Counseling.

[9]  P. Nafstad,et al.  Genetics and Gene-Environment Interactions in Atopic Diseases , 2007, Human Heredity.

[10]  Aart Hendriks,et al.  Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. , 2000, The Journal of medicine and philosophy.

[11]  Michael Tanner,et al.  Healthy competition: What's holding back health care and how to free it. , 2005, AHIP Coverage.

[12]  J. Otten,et al.  The charitable trust as a model for genomic biobanks. , 2004, The New England journal of medicine.

[13]  Meredith Wadman Genetics bill cruises through Senate , 2008, Nature.

[14]  Francis S Collins,et al.  The genome gets personal--almost. , 2008, JAMA.

[15]  Pascal Borry,et al.  Direct-to-consumer genetic testing: more questions than benefits? , 2008, Personalized medicine.

[16]  Muin J. Khoury,et al.  Letting the genome out of the bottle--will we get our wish? , 2008, The New England journal of medicine.

[17]  B. Prainsack What are the stakes? Genetic nondiscrimination legislation and personal genomics. , 2008, Personalized medicine.

[18]  R. Altman,et al.  Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. , 2007, Pharmacogenomics.

[19]  G. Javitt,et al.  A Case Study of Personalized Medicine , 2008, Science.

[20]  M. Cornel,et al.  Recreational genomics? Dreams and fears on genetic susceptibility screening , 2008, European Journal of Human Genetics.

[21]  T. Spector,et al.  Genetic influences on female infidelity and number of sexual partners in humans: a linkage and association study of the role of the vasopressin receptor gene (AVPR1A). , 2004, Twin research : the official journal of the International Society for Twin Studies.

[22]  P. Borry Europe to ban direct-to-consumer genetic tests? , 2008, Nature Biotechnology.

[23]  Barbara Prainsack,et al.  Personal genomes: Misdirected precaution , 2008, Nature.